{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:25:22Z","timestamp":1771550722569,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.amjoto.2021.103166","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T03:56:07Z","timestamp":1627358167000},"page":"103166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Consistent multimodality approach to oral cavity and high-risk oropharyngeal cancer in veterans"],"prefix":"10.1016","volume":"42","author":[{"given":"David J.","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan O.","family":"Kemnade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlad C.","family":"Sandulache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjoto.2021.103166_bb0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.oraloncology.2008.05.017","article-title":"Current concepts in management of oral cancer\u2013surgery","volume":"45","author":"Shah","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.amjoto.2021.103166_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cncr.27727","article-title":"An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair","volume":"119","author":"Dahlstrom","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.amjoto.2021.103166_bb0015","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.2015.64.6448","article-title":"Proposed staging system for patients with HPV-related oropharyngeal cancer based on nasopharyngeal cancer N categories","volume":"34","author":"Dahlstrom","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjoto.2021.103166_bb0020","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjoto.2021.103166_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.amjoto.2021.103166_bb0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer network for staging (ICON-S): a multicentre cohort study","volume":"17","author":"O'Sullivan","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjoto.2021.103166_bb0035","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1158\/1078-0432.CCR-17-0721","article-title":"High-risk TP53 mutations are associated with extranodal extension in Oral cavity squamous cell carcinoma","volume":"24","author":"Sandulache","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.amjoto.2021.103166_bb0040","article-title":"Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 field based meeting","author":"Sandulache","year":"2019"},{"key":"10.1016\/j.amjoto.2021.103166_bb0045","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/hed.23740","article-title":"Oropharyngeal squamous cell carcinoma in the veteran population: association with traditional carcinogen exposure and poor clinical outcomes","volume":"37","author":"Sandulache","year":"2015","journal-title":"Head Neck"},{"issue":"12","key":"10.1016\/j.amjoto.2021.103166_bb0050","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/cncr.32025","article-title":"Validation of NRG oncology\/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials","volume":"125","author":"Fakhry","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.amjoto.2021.103166_bb0055","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1186\/s12885-020-07427-7","article-title":"Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma","volume":"20","author":"Elhalawani","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.amjoto.2021.103166_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3342\/ceo.2011.4.1.1","article-title":"Current management of advanced resectable oral cavity squamous cell carcinoma","volume":"4","author":"Ow","year":"2011","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.amjoto.2021.103166_bb0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1245\/s10434-016-5629-x","article-title":"Clinical outcomes of taiwanese patients with cT4 Oral cavity squamous cell carcinoma: toward the identification of the optimal initial treatment approach for cT4b patients","volume":"24","author":"Liao","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjoto.2021.103166_bb0070","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-11-0046","article-title":"Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer","volume":"17","author":"Sano","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.amjoto.2021.103166_bb0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.CCR-11-2260","article-title":"TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence","volume":"18","author":"Skinner","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.amjoto.2021.103166_bb0080","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.molcel.2014.04.024","article-title":"Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation","volume":"54","author":"Zhou","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.amjoto.2021.103166_bb0085","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1158\/0008-5472.CAN-14-2735","article-title":"Evolutionary action score of TP53 identifies high-risk mutations associated with decreased survival and increased distant metastases in head and neck cancer","volume":"75","author":"Neskey","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjoto.2021.103166_bb0090","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1158\/0008-5472.CAN-14-2729","article-title":"Evolutionary action score of TP53 coding variants is predictive of platinum response in head and neck cancer patients","volume":"75","author":"Osman","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjoto.2021.103166_bb0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/micr.30154","article-title":"Outcomes of microvascular free tissue transfer in twice-irradiated patients","volume":"37","author":"Clancy","year":"2017","journal-title":"Microsurgery"},{"key":"10.1016\/j.amjoto.2021.103166_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13014-020-01531-5","article-title":"The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer","volume":"15","author":"Ruhle","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.amjoto.2021.103166_bb0105","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjoto.2021.103166_bb0110","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.annonc.2020.04.001","article-title":"Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study","volume":"31","author":"Ferris","year":"2020","journal-title":"Ann Oncol"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070921002672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070921002672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:09:26Z","timestamp":1759295366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070921002672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0196070921002672"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2021.103166","relation":{},"ISSN":["0196-0709"],"issn-type":[{"value":"0196-0709","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consistent multimodality approach to oral cavity and high-risk oropharyngeal cancer in veterans","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2021.103166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103166"}}